List of Aricept drug patents

Aricept is owned by Eisai Inc.

Aricept contains Donepezil Hydrochloride.

Aricept has a total of 1 drug patent out of which 0 drug patents have expired.

Aricept was authorised for market use on 23 July, 2010.

Aricept is available in tablet;oral dosage forms.

The generics of Aricept are possible to be released after 04 October, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8481565 EISAI INC Method for stabilizing anti-dementia drug
Oct, 2026

(3 years from now)

Drugs and Companies using DONEPEZIL HYDROCHLORIDE ingredient

Market Authorisation Date: 23 July, 2010

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of ARICEPT before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic